When did Treace Medical Concepts, Inc. report Q4 2024 earnings?

Treace Medical Concepts, Inc. (TMCI) reported Q4 2024 earnings on February 27, 2025 after market close.

What were Treace Medical Concepts, Inc.'s Q4 2024 revenue and EPS?

Treace Medical Concepts, Inc. reported revenue of $68.7M and eps of $-0.01 for Q4 2024.

Did Treace Medical Concepts, Inc. beat estimates in Q4 2024?

Revenue beat the consensus estimate of $67.2M by $1.5M. EPS beat the consensus estimate of $-0.04 by $0.03.

Where can I find Treace Medical Concepts, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-029029) directly on SEC EDGAR. The filing index links above go to sec.gov.

Treace Medical Concepts, Inc. TMCI Q4 2024 Annual earnings

Reported February 27, 2025 · After market close

Revenue$68.7MBeat by $1.5M

EPS-$0.01Beat by $0.03

Revenue estimate$67.2M

EPS estimate-$0.04

Next report

Aug 7, 2026 (In 1 week)

Revenue estimate$44.0M

EPS estimate-$0.30

Financials

Q4 2024

Income statement

See full

Revenue$68.7M+10.4%

Gross profit$55.5M+9.3%

Operating income-$204.0K+97.0%

Net income-$501.0K+92.0%

EPS (diluted)-$0.01+90.0%

Balance sheet

See full

Cash & equivalents$11.4M-12.6%

Total debt$69.7M-0.9%

Total equity$112.9M-18.2%

Total assets$217.1M-13.8%

Cash flow

See full

Operating cash flow-$4.2M—

CapEx$3.1M+36.7%

Free cash flow-$7.3M-324%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$463.49M-41.1%

Enterprise value$521.79M-38.2%

P/S2.2×-2.0×

Profitability

See full

Gross margin80.4%-0.8pp

Operating margin-26.6%-0.8pp

Net margin-26.6%+0.2pp

FCF margin-23.3%-1.2pp

Returns & leverage

See full

Return on equity-44.4%-4.4pp

Debt / equity0.6×+0.1×

Current ratio4.6×+0.2×

Versus estimates

Revenue

Q1 2026$47.2MBeat by $1.2M Q4 2025$62.5MBeat by $670.3K Q3 2025$50.2MMiss by $11.5M Q2 2025$47.4MMiss by $2.5M Q1 2025$52.6MBeat by $3.1M

Q4 2024$68.7MBeat by $1.5M

Diluted EPS

Q1 2026-$0.28Beat by $0.03 Q4 2025-$0.12Beat by $0.03 Q3 2025-$0.26Beat by $0.02 Q2 2025-$0.28Beat by $0.01 Q1 2025-$0.25Beat by $0.06

Q4 2024-$0.01Beat by $0.03

Ask the moment Treace Medical Concepts, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Treace Medical Concepts, Inc. report Q4 2024 earnings?: Treace Medical Concepts, Inc. (TMCI) reported Q4 2024 earnings on February 27, 2025 after market close.
What were Treace Medical Concepts, Inc.'s Q4 2024 revenue and EPS?: Treace Medical Concepts, Inc. reported revenue of $68.7M and eps of $-0.01 for Q4 2024.
Did Treace Medical Concepts, Inc. beat estimates in Q4 2024?: Revenue beat the consensus estimate of $67.2M by $1.5M. EPS beat the consensus estimate of $-0.04 by $0.03.
Where can I find Treace Medical Concepts, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-029029) directly on SEC EDGAR. The filing index links above go to sec.gov.